PCI Biotech pivotal study for FimaChem
PCI Biotech pivotal study for FimaChem in Inoperable Cholangiocarcinoma https://www.clinicaltrialsregister.eu/ctr-search/search?query=2018-002647-29
"Randomised, Open-Label, Phase 2 to Assess the Safety, Tolerability and Efficacy of Fimaporfin-Induced Photochemical Internalisation of Gemcitabine...."
"Randomised, Open-Label, Phase 2 to Assess the Safety, Tolerability and Efficacy of Fimaporfin-Induced Photochemical Internalisation of Gemcitabine...."
Redigert 11.02.2019 kl 14:48
Du må logge inn for å svare
Iphone7s
12.02.2019 kl 00:45
435